Scholarlink

<p>Neural damage, which could be characterized by demyelination and neuropathic pain, is a hallmark of leprosy, driven primarily by the interaction of <i>Mycobacterium leprae</i> with peripheral nerves, particularly Schwann cells. The role of indoleamine 2,3-dioxygenase (IDO) in neuroinflammation and neurodegeneration has been suggested; however, its precise contribution to leprosy-associated neuropathy remains poorly understood. This study aimed to determine whether variations in serum IDO activity, inferred from the kynurenine/tryptophan (Kyn/trp) ratio, could assist in distinguishing leprosy-associated neuropathy from other peripheral neuropathies. Additionally, we investigated the potential correlation between the increase in the Kyn/trp ratio and the extent of neural impairment. Based on clinical and electrophysiological evaluations, neural damage was classified into four severity types. Kyn/trp ratio was significantly higher in patients with leprosy neuropathy than in those with non-leprosy neuropathies. Moreover, we observed that patients exhibiting no sensory or motor responses have the highest IDO levels. Thus, the data presented here suggest that given the challenges in diagnosing leprosy neuropathy, IDO-1 activity may serve as a complementary diagnostic tool to help distinguish leprosy from other peripheral neuropathies.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Indoleamine 2,3-Dioxygenase: A Potential Biomarker for Neural Damage Severity of Leprosy Neuropathy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月31日

查看全文
  • Atta Ur Rahman,
  • Raíssa Couto Santana,
  • Mylena Masseno de Pinho Pereira,
  • Claudia Luciana Santos Moura,
  • Jéssica Araújo Paixão de Oliveira,
  • Euzenir Nunes Sarno,
  • Gilberto Marcelo Sperandio da Silva,
  • Márcia Rodrigues Jardim,
  • Roberta Olmo Pinheiro

摘要

Neural damage, which could be characterized by demyelination and neuropathic pain, is a hallmark of leprosy, driven primarily by the interaction of Mycobacterium leprae with peripheral nerves, particularly Schwann cells. The role of indoleamine 2,3-dioxygenase (IDO) in neuroinflammation and neurodegeneration has been suggested; however, its precise contribution to leprosy-associated neuropathy remains poorly understood. This study aimed to determine whether variations in serum IDO activity, inferred from the kynurenine/tryptophan (Kyn/trp) ratio, could assist in distinguishing leprosy-associated neuropathy from other peripheral neuropathies. Additionally, we investigated the potential correlation between the increase in the Kyn/trp ratio and the extent of neural impairment. Based on clinical and electrophysiological evaluations, neural damage was classified into four severity types. Kyn/trp ratio was significantly higher in patients with leprosy neuropathy than in those with non-leprosy neuropathies. Moreover, we observed that patients exhibiting no sensory or motor responses have the highest IDO levels. Thus, the data presented here suggest that given the challenges in diagnosing leprosy neuropathy, IDO-1 activity may serve as a complementary diagnostic tool to help distinguish leprosy from other peripheral neuropathies.

Graphical Abstract